Ground Breaking Research targeting treatment of TBI

<p>Tyler Pieron chats with Dr. John Lukens, PhD, who leads a team of researchers at the University of Virginia investigating the cellular and molecular pathways that contribute to neuroinflammation and central nervous system (CNS)-related tissue damage. Dr. Lukens shares with us the latest research about the intersection of the immune system in neurological issues, such as Traumatic Brain Injuries, Alzheimer’s Disease, Multiple Sclerosis, and Autism, among others. He shares groundbreaking research that provide new insights into both the causes and consequences of meningeal lymphatic dysfunction in TBI and suggest that therapeutics targeting the meningeal lymphatic system may offer strategies to treat TBI.</p><p><a rel="payment" href="https://www.paypal.com/donate?hosted_button_id=DPPU22JG5EM6Y">Support the show</a> (https://www.paypal.com/donate?hosted_button_id=DPPU22JG5EM6Y)</p>